Endocrine Board Review, 15th Edition
Image For Activity Cover
Expires on Dec 31, 2024
Member: $179.00
Non-Member: $229.00
In-Training Member: $149.00
Resident Member: $179.00
Resident Non-Member: $229.00
Credit Offered
55 AMA PRA Category 1 Credits
55 ABIM-MOC Points
55 Participation Credits
  • Course Description
  • Target Audience
  • Learning Objectives
  • Accreditation Statement
  • Faculty and Disclosures
  • Recommended
The Endocrine Board Review (EBR) is a board examination preparation course designed both for endocrine fellows who have completed or are nearing completion of their fellowship and are preparing to sit the board certification exam, and for practicing endocrinologists in search of a comprehensive self-assessment of endocrinology, either to prepare for recertification or to update their practice. The EBR 15th Edition book contains 220 case-based questions with detailed answer rationale. This product is ideal for a self-motivated learner who prefers to study from a book alone. 
This activity is intended for endocrine fellows planning for initial certification, practicing endocrinologists preparing for an MOC assessment, or physicians seeking an in-depth review of endocrinology. The secondary target audience includes advanced practice nurses and physician assistants.

Upon completion of this educational activity, learners will be able to: 

  • Demonstrate enhanced medical knowledge and clinical skills across all major areas of endocrinology.
  • Apply knowledge and skills in diagnosing, managing, and treating a wide spectrum of endocrine disorders.
  • Successfully complete the board examination for certification or recertification in the subspecialty of endocrinology, diabetes, and metabolism.

The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Endocrine Society has achieved Accreditation with Commendation.

AMA PRA Category 1 Credit
The Endocrine Society designates each activity in this course for a maximum of 55 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. While offering CME credits noted above, this program is not intended to provide extensive training or certification in the field.

Please note that while other accrediting bodies accept AMA PRA Category 1 credit, we can only award and report this credit for MDs/DOs. For those outside of this accreditation, please complete the participation evaluation and use that certificate as proof of attendance to submit to your accrediting body.

Maintenance of Certification (MOC)
Successful completion of each CME activity in this course, which includes participation in the evaluation component, enables the participant to earn up to 55 points in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

For questions about content or obtaining CME credit, please contact the Endocrine Society at info@endocrine.org

Frances J. Hayes, MB BCh BAO - Program Chair
Associate Clinical Chief of Endocrinology
Massachusetts General Hospital
Associate Professor of Medicine
Harvard Medical School

John D. Carmichael, MD
Co-Director, USC Pituitary Center
Associate Professor of Clinical Medicine
Division of Endocrinology, Diabetes and Metabolism
Keck School of Medicine of University of Southern California

Natalie Cusano, MD, MS
Professor of Medicine
Zucker School of Medicine at Hofstra/Northwell
Director of Bone Metabolism Program
Division of Endocrinology at Lenox Hill Hospital

Tobias Else, MD
Associate Professor
Division of Metabolism, Endocrinology, and Diabetes
University of Michigan

Jacqueline Jonklaas, MD, PhD, MPH
Division of Endocrinology
Georgetown University Medical Center

Sangeeta R. Kashyap, MD
Assistant Chief of Clinical Affairs
Division of Endocrinology, Diabetes and Metabolism
Weill Cornell Medicine New York Presbyterian

Margaret Flynn Lippincott, MD
Assistant Professor of Medicine
Harvard Medical School
Physician Investigator
Reproductive Endocrine Unit
Massachusetts General Hospital

Marie E. McDonnell, MD
Section Chief, Diabetes Section
Division of Endocrinology Diabetes and Hypertension
Brigham and Women's Hospital
Associate Professor of Medicine
Harvard Medical School

Stephanie T. Page, MD, PhD
Robert B. McMillen Professor of Medicine in Lipid Research
Division Head, Metabolism, Endocrinology and Nutrition
Co-Director, UW Medicine Diabetes Institute
University of Washington

Anne L. Peters, MD
Professor of Clinical Medicine
Keck School of Medicine of University of Southern California

As a provider of CME accredited by the Accreditation Council for Continuing Medical Education, the Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the Endocrine Society’s peer reviewers.

The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion.

The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.

The following faculty reported relevant financial relationships:

John D. Carmichael, MD, Novo Nordisk: Advisory Board Member; Recordati: Advisory Board Member; Camurus: Advisory Board Member

Natalie Cusano, MD, MS, Takeda/Shire: Research Funds; Ascendis Pharma: Consultant; Alexion: Speaker

Tobias Else, MD, Corcept Pharmaceuticals: Co-Investigator; Merck: Advisor Board Member, Co-Investigator; Lantheus: Advisory Board Member; VHL Alliance: Committee Member

Sangeeta Kashyap, MD, GI Dynamics: Investigator, Consultant; Fractyl: Research Support; Gila Therapeutics: Chief Medical Officer

Marie E. McDonnell, MD, Eisai: Trial Event Adjudicator; Lilly, Inc.: Research Grant

Stephanie Page, MD, PhD, UpToDate: Editor

Anne Peters, MD, Abbot Diabetes Care: Advisory Board Member, Research Support; Medscape: Advisory Board Member; Novo Nordisk: Advisory Board Member; Vertex: Advisory Board Member; Zealand: Advisory Board Member; Blue Circle Health: Consultant; Dexcom: Research Support; Insulet: Research Support; Omada Health: Stock Options; Teladoc: Stock Options

The following faculty reported no relevant financial relationships: Frances J. Hayes, MB BCh BAO; Jacqueline Jonklaas, MD, PhD, MPH; and Margaret Flynn Lippincott, MD

The medical editor for this activity reported no relevant financial relationships: Abbie L. Young, MS, CGC, ELS(D)

Endocrine Society staff associated with the development of content for this activity reported no relevant financial relationships.


The activity is not supported by educational grant(s) or other funds from any commercial supporters.  

     EndoCareers | Contact Us | Privacy Policy | Terms of Use CONNECT WITH US                
       © 2021 Copyright Endocrine Society. All rights reserved.
2055 L Street NW, Suite 600 | Washington, DC 20036      
 202.971.3636 | 888.363.6274
Android App Download IOS App Download Powered By